Literature DB >> 20405503

Primary amyloidosis presenting as upper limb multiple mononeuropathies.

Jennifer A Tracy1, Peter J Dyck, P James B Dyck.   

Abstract

Peripheral neuropathy in primary (AL) amyloidosis is usually lower-limb predominant, length-dependent, symmetrical, and affects small (pain and autonomic) fibers, as much or more than large fibers. We report a patient with stepwise progressive, multiple upper limb mononeuropathies that were due to nerve biopsy-proven primary amyloidosis (lambda light chain), with no systemic or autonomic features. Recognition that light chain amyloidosis may be the cause of a multiple mononeuropathy pattern adds to the differential diagnosis of this clinical phenotype.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20405503      PMCID: PMC2947379          DOI: 10.1002/mus.21561

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  15 in total

1.  Peripheral nerve amyloidosis in sural nerve biopsies: a clinicopathologic analysis of 13 cases.

Authors:  B Rajani; V Rajani; R A Prayson
Journal:  Arch Pathol Lab Med       Date:  2000-01       Impact factor: 5.534

2.  Dissociated sensation in amylidosis. Compound action potential, quantitative histologic and teased-fiber, and electron microscopic studies of sural nerve biopsies.

Authors:  P J Dyck; E H Lambert
Journal:  Arch Neurol       Date:  1969-05

3.  The splanchnic autonomic outflow in amyloid neuropathy and Tangier disease.

Authors:  P A Low; P J Dyck; H Okazaki; R Kyle; R D Fealey
Journal:  Neurology       Date:  1981-04       Impact factor: 9.910

4.  Amyloidomas of the nervous system: a monoclonal B-cell disorder with monotypic amyloid light chain lambda amyloid production.

Authors:  R H Laeng; H J Altermatt; B W Scheithauer; D R Zimmermann
Journal:  Cancer       Date:  1998-01-15       Impact factor: 6.860

5.  The natural history of peripheral neuropathy in primary systemic amyloidosis.

Authors:  J J Kelly; R A Kyle; P C O'Brien; P J Dyck
Journal:  Ann Neurol       Date:  1979-07       Impact factor: 10.422

6.  Primary solitary amyloidoma of thoracic spine: a case report and review of the literature.

Authors:  A Unal; P-N Sütlap; M Kýyýk
Journal:  Clin Neurol Neurosurg       Date:  2003-07       Impact factor: 1.876

7.  Quantitative sensation and autonomic test abnormalities in transthyretin amyloidosis polyneuropathy.

Authors:  Dong Hwee Kim; Steven R Zeldenrust; Phillip A Low; Peter J Dyck
Journal:  Muscle Nerve       Date:  2009-09       Impact factor: 3.217

8.  Cool, warm, and heat-pain detection thresholds: testing methods and inferences about anatomic distribution of receptors.

Authors:  P J Dyck; I Zimmerman; D A Gillen; D Johnson; J L Karnes; P C O'Brien
Journal:  Neurology       Date:  1993-08       Impact factor: 9.910

9.  Response rates and survival in primary systemic amyloidosis.

Authors:  M A Gertz; R A Kyle; P R Greipp
Journal:  Blood       Date:  1991-01-15       Impact factor: 22.113

10.  Transthyretin amyloidosis presenting with multifocal demyelinating mononeuropathies.

Authors:  Hannah R Briemberg; Anthony A Amato
Journal:  Muscle Nerve       Date:  2004-02       Impact factor: 3.217

View more
  4 in total

1.  MRI of pathology-proven peripheral nerve amyloidosis.

Authors:  Gavin A McKenzie; Stephen M Broski; Benjamin M Howe; Robert J Spinner; Kimberly K Amrami; Angela Dispenzieri; Michael D Ringler
Journal:  Skeletal Radiol       Date:  2016-10-12       Impact factor: 2.199

Review 2.  Amyloid neuropathies.

Authors:  Susan C Shin; Jessica Robinson-Papp
Journal:  Mt Sinai J Med       Date:  2012 Nov-Dec

3.  Transthyretin amyloid neuropathy has earlier neural involvement but better prognosis than primary amyloid counterpart: an answer to the paradox?

Authors:  Adam J Loavenbruck; Wolfgang Singer; Michelle L Mauermann; Paola Sandroni; P James B Dyck; Morie Gertz; Christopher J Klein; Phillip A Low
Journal:  Ann Neurol       Date:  2016-07-25       Impact factor: 10.422

Review 4.  Neuromuscular issues in systemic disease.

Authors:  Wolfgang Grisold; Anna Grisold
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 6.030

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.